Search

everythinglearnresearchcommunity

for

Search:↓

Combination of 17α-estradiol and minoxidil improves hair growth and reduces hair loss in most patients.

Higher levels of the DP2 receptor may lead to hair loss.

The chapter explains the causes of excessive hair growth and masculinization in women and how to measure hormone levels related to these conditions.

Hair follicle cells can help heal wounds and study skin diseases.

Backhousia citriodora leaf extract effectively reduces oily skin across different ethnic groups.

Wearing a wig caused a woman's skin condition to worsen due to pressure from the wig's fasteners.

Talquetamab may cause hair loss and skin issues.

ULBP3 levels are higher in Tinea capitis patients and may help predict the disease's severity.

Teak seed extract is safe and reduces pain in mice.

The most effective treatments for hair loss are minoxidil, finasteride, PRP, and hair transplants, with steroids and immunosuppressants for autoimmune types.

Lichen Planopilaris is a hair loss condition best treated early with various medications, including hydroxychloroquine, to prevent permanent baldness.

The new scalp treatment preserves hair color, reduces hair loss, and maintains hair strength.

Stabilizing HIF-1A in hair follicles may reduce oxidative stress and promote hair growth by increasing glycolysis.

Researchers found a new area on chromosome 2 linked to a genetic hair loss condition.

Dermoscopy can help diagnose tinea capitis in children by looking for comma hairs, black dots, and broken hairs with white bands.

Infliximab was effective in treating a scalp condition that did not respond to other treatments.

About 17% of people in France have dandruff, and those with dandruff are more likely to have sensitive and itchy scalps.

A man's scalp hair loss was due to a combined melanocytic nevus and alopecia areata, suggesting a possible link between the two conditions.

The CO₂ laser is better for hair transplantation because it causes less damage than the Ho:YAG laser.

FOXC1 boosts SFRP1 in hair loss, suggesting new treatments.

Injections of special skin cells showed potential in treating hair loss, with some participants experiencing increased hair density.

Finasteride doesn't effectively treat hair loss in postmenopausal women.

AGA causes hair loss by shrinking hair follicles due to DHT binding, and can be treated with finasteride and minoxidil.

Cells from balding scalps have more androgen receptors than cells from non-balding scalps.

Male hormones, particularly DHT, are linked to male pattern hair loss, and treatments like finasteride can help, but they don't work for postmenopausal women's hair loss, which may have different causes.

Minoxidil works better for female hair loss, but cyproterone reduces scalp oiliness and causes menstrual issues.

Finasteride effectively treats baldness but may cause sexual side effects.

Dutasteride 0.5 mg works better than finasteride and placebo for increasing hair in men with hair loss.

The document concludes that accurate diagnosis and personalized treatment are important for skin problems in women with PCOS.

Activating the Wnt/β-catenin pathway could lead to new hair loss treatments.